Clinical Trial Detail

NCT ID NCT02642913
Title Study of Enzalutamide With and Without Sorafenib in Advanced Hepatocellular Carcinoma Patients
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Memorial Sloan Kettering Cancer Center
Indications

hepatocellular carcinoma

Therapies

Enzalutamide

Sorafenib

Age Groups: adult

No variant requirements are available.